• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低级别胶质瘤中的端粒维持途径:来自基因亚型和端粒长度动态变化的见解

Telomere Maintenance Pathways in Lower-Grade Gliomas: Insights from Genetic Subtypes and Telomere Length Dynamics.

作者信息

Hakobyan Meline, Binder Hans, Arakelyan Arsen

机构信息

Bioinformatics Group, Institute of Molecular Biology National Academy of Sciences of the Republic of Armenia (NAS RA), Yerevan 0014, Armenia.

Interdisciplinary Centre for Bioinformatics, University of Leipzig, 04103 Leipzig, Germany.

出版信息

Int J Mol Sci. 2025 Apr 28;26(9):4175. doi: 10.3390/ijms26094175.

DOI:10.3390/ijms26094175
PMID:40362411
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12071676/
Abstract

Telomere maintenance mechanisms (TMMs) play a critical role in cancer biology, particularly in lower-grade gliomas (LGGs), where telomere dynamics and pathway activity remain poorly understood. In this study, we analyzed TCGA-LGG and CGGA datasets, focusing on telomere length variations, pathway activity, and survival data across IDH subtypes. Additional validation was performed using the GEO COPD and GBM datasets, ensuring consistency in data processing and batch effect correction. Our analysis revealed significant differences in TEL pathway activation between Short- and Long-TL groups, emphasizing the central role of TERT in telomere maintenance. In contrast, ALT pathway activation displayed subtype-specific patterns, with IDH-wt tumors exhibiting the highest ALT activity, primarily driven by the RAD51 branch. Validation using CGGA data confirmed these findings, demonstrating consistent TEL and ALT pathway behaviors across datasets. Additionally, genetic subtype analysis revealed substantial telomere length variability associated with ATRX and IDH mutation status. Notably, IDHwt-ATRX WT tumors exhibited the shortest telomere length and the highest ALT pathway activity. These findings highlight distinct telomere regulatory dynamics across genetic subtypes of LGG and provide new insights into potential therapeutic strategies targeting telomere maintenance pathways.

摘要

端粒维持机制(TMMs)在癌症生物学中起着关键作用,尤其是在低级别胶质瘤(LGGs)中,而在低级别胶质瘤中端粒动态变化和通路活性仍知之甚少。在本研究中,我们分析了TCGA-LGG和CGGA数据集,重点关注不同异柠檬酸脱氢酶(IDH)亚型的端粒长度变化、通路活性和生存数据。使用GEO慢性阻塞性肺疾病(COPD)和胶质母细胞瘤(GBM)数据集进行了额外验证,确保了数据处理的一致性和批次效应校正。我们的分析揭示了短端粒长度(Short-TL)组和长端粒长度(Long-TL)组之间端粒酶逆转录酶(TERT)通路激活存在显著差异,强调了TERT在端粒维持中的核心作用。相比之下,端粒延长替代机制(ALT)通路激活呈现出亚型特异性模式,异柠檬酸脱氢酶野生型(IDH-wt)肿瘤的ALT活性最高,主要由RAD51分支驱动。使用CGGA数据进行的验证证实了这些发现,表明各数据集之间TERT和ALT通路行为一致。此外,基因亚型分析揭示了与ATRX和IDH突变状态相关的显著端粒长度变异性。值得注意的是,IDH野生型-ATRX野生型(IDHwt-ATRX WT)肿瘤的端粒长度最短,ALT通路活性最高。这些发现突出了低级别胶质瘤不同基因亚型之间独特的端粒调控动态,并为靶向端粒维持通路的潜在治疗策略提供了新见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/24e9885ce33e/ijms-26-04175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/155fe309b832/ijms-26-04175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/a4772804273d/ijms-26-04175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/c591fc530992/ijms-26-04175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/8700e923ab94/ijms-26-04175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/70e5b1b9ca08/ijms-26-04175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/24e9885ce33e/ijms-26-04175-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/155fe309b832/ijms-26-04175-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/a4772804273d/ijms-26-04175-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/c591fc530992/ijms-26-04175-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/8700e923ab94/ijms-26-04175-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/70e5b1b9ca08/ijms-26-04175-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3dd/12071676/24e9885ce33e/ijms-26-04175-g006.jpg

相似文献

1
Telomere Maintenance Pathways in Lower-Grade Gliomas: Insights from Genetic Subtypes and Telomere Length Dynamics.低级别胶质瘤中的端粒维持途径:来自基因亚型和端粒长度动态变化的见解
Int J Mol Sci. 2025 Apr 28;26(9):4175. doi: 10.3390/ijms26094175.
2
Alternative lengthening of telomeres is the major telomere maintenance mechanism in astrocytoma with isocitrate dehydrogenase 1 mutation.端粒的非经典延长是 IDH1 突变星形细胞瘤中端粒维持的主要机制。
J Neurooncol. 2020 Mar;147(1):1-14. doi: 10.1007/s11060-020-03394-y. Epub 2020 Jan 20.
3
Correlation between IDH, ATRX, and TERT promoter mutations in glioma.胶质瘤中 IDH、ATRX 和 TERT 启动子突变的相关性。
Brain Tumor Pathol. 2020 Apr;37(2):33-40. doi: 10.1007/s10014-020-00360-4. Epub 2020 Mar 29.
4
Alternative lengthening of telomeres in molecular subgroups of paediatric high-grade glioma.儿童高级别胶质瘤分子亚群中端粒的替代性延长。
Childs Nerv Syst. 2021 Mar;37(3):809-818. doi: 10.1007/s00381-020-04933-8. Epub 2020 Oct 31.
5
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.端粒维持的机制及恶性脑胶质瘤相关的治疗弱点。
Neuro Oncol. 2024 Jun 3;26(6):1012-1024. doi: 10.1093/neuonc/noae016.
6
Mutant IDH1 Cooperates with ATRX Loss to Drive the Alternative Lengthening of Telomere Phenotype in Glioma.突变 IDH1 与 ATRX 缺失协同作用驱动胶质瘤端粒的替代性延长表型。
Cancer Res. 2018 Jun 1;78(11):2966-2977. doi: 10.1158/0008-5472.CAN-17-2269. Epub 2018 Mar 15.
7
Adult infiltrating gliomas with WHO 2016 integrated diagnosis: additional prognostic roles of ATRX and TERT.2016年世界卫生组织综合诊断的成人浸润性胶质瘤:ATRX和TERT的额外预后作用
Acta Neuropathol. 2017 Jun;133(6):1001-1016. doi: 10.1007/s00401-017-1690-1. Epub 2017 Mar 2.
8
SMARCAL1 loss and alternative lengthening of telomeres (ALT) are enriched in giant cell glioblastoma.SMARCAL1缺失和端粒替代延长(ALT)在巨细胞胶质母细胞瘤中富集。
Mod Pathol. 2021 Oct;34(10):1810-1819. doi: 10.1038/s41379-021-00841-7. Epub 2021 Jun 8.
9
Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma.全外显子组测序确定ATRX突变是低级别胶质瘤的关键分子决定因素。
Oncotarget. 2012 Oct;3(10):1194-203. doi: 10.18632/oncotarget.689.
10
The level of activity of the alternative lengthening of telomeres correlates with patient age in IDH-mutant ATRX-loss-of-expression anaplastic astrocytomas.端粒的替代性延长活动水平与 IDH 突变 ATRX 表达缺失型间变性星形细胞瘤患者的年龄相关。
Acta Neuropathol Commun. 2019 Nov 9;7(1):175. doi: 10.1186/s40478-019-0833-0.

引用本文的文献

1
Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers.离子化治疗胶质母细胞瘤:铁死亡机制与治疗前沿。
Cell Death Discov. 2025 Aug 26;11(1):407. doi: 10.1038/s41420-025-02711-6.

本文引用的文献

1
Imetelstat, a novel, first-in-class telomerase inhibitor: Mechanism of action, clinical, and translational science.依特司他,一种新型的首创端粒酶抑制剂:作用机制、临床和转化科学。
Clin Transl Sci. 2024 Nov;17(11):e70076. doi: 10.1111/cts.70076.
2
Pan-cancer analysis of telomere maintenance mechanisms.泛癌分析端粒维持机制。
J Biol Chem. 2024 Jun;300(6):107392. doi: 10.1016/j.jbc.2024.107392. Epub 2024 May 18.
3
Mechanisms of telomere maintenance and associated therapeutic vulnerabilities in malignant gliomas.端粒维持的机制及恶性脑胶质瘤相关的治疗弱点。
Neuro Oncol. 2024 Jun 3;26(6):1012-1024. doi: 10.1093/neuonc/noae016.
4
Distinct modes of telomere synthesis and extension contribute to Alternative Lengthening of Telomeres.端粒合成和延长的不同模式促成了端粒的替代延长。
iScience. 2023 Dec 11;27(1):108655. doi: 10.1016/j.isci.2023.108655. eCollection 2024 Jan 19.
5
PSF toolkit: an R package for pathway curation and topology-aware analysis.PSF工具包:一个用于通路整理和拓扑感知分析的R软件包。
Front Genet. 2023 Aug 23;14:1264656. doi: 10.3389/fgene.2023.1264656. eCollection 2023.
6
The Chromatin Remodeler ATRX: Role and Mechanism in Biology and Cancer.染色质重塑因子ATRX:在生物学和癌症中的作用及机制
Cancers (Basel). 2023 Apr 10;15(8):2228. doi: 10.3390/cancers15082228.
7
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011-2017): a multicenter retrospective study from CGGA.中国弥漫性神经胶质瘤不同分子亚型患者的临床管理和生存结局(2011-2017):来自 CGGA 的一项多中心回顾性研究。
Cancer Biol Med. 2022 Nov 1;19(10):1460-76. doi: 10.20892/j.issn.2095-3941.2022.0469.
8
The telomere maintenance mechanism spectrum and its dynamics in gliomas.端粒维持机制谱及其在神经胶质瘤中的动态变化。
Genome Med. 2022 Aug 11;14(1):88. doi: 10.1186/s13073-022-01095-x.
9
The WHO 2021 Classification of Central Nervous System tumours: a practical update on what neurosurgeons need to know-a minireview.世卫组织 2021 年中枢神经系统肿瘤分类:神经外科医生需要了解的实用更新——一篇迷你综述。
Acta Neurochir (Wien). 2022 Sep;164(9):2453-2464. doi: 10.1007/s00701-022-05301-y. Epub 2022 Jul 26.
10
The Emerging Roles of Rad51 in Cancer and Its Potential as a Therapeutic Target.Rad51在癌症中的新作用及其作为治疗靶点的潜力。
Front Oncol. 2022 Jul 7;12:935593. doi: 10.3389/fonc.2022.935593. eCollection 2022.